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The negative factor (Nef) is one of six accessory proteins from primate lentiviruses (HIV-1, HIV-2, and SIV). It leads to high
levels of viremia and the progression to AIDS in monkeys and humans. In this study, we demonstrated that Nef from HIV-1
binds to the regulatory subunit (p85) of phosphatidylinositol-3-kinase (PI3K). This interaction depended on the C-terminus of
p85 and Nef. Moreover, PI3K was required to activate the Nef-associated p21-activated kinase (PAK). Finally, inhibition of
PI3K blocked the activation of PAK and decreased the production of viral particles to levels observed with the Nef-deleted
provirus. We conclude that Nef assembles a multiprotein signaling complex which is required for the optimal replication of
HIV-1. © 2002 Elsevier Science (USA)INTRODUCTION
The accessory protein Nef from primate lentiviruses
HIV-1, HIV-2, and SIV is a myristoylated, membrane-as-
sociated protein (Herna Renkema and Saksela, 2000). In
contrast to the weak phenotype in immortalized cell
lines, Nef is important for the development of AIDS in
rhesus macaques and humans (Kestler et al., 1991; Kirch-
hoff et al., 1995). Indeed, certain truncations of Nef are
associated with a delayed onset of AIDS in infected
individuals (Deacon et al., 1995). Nef is also required for
HIV-1 infection in the SCID-hu mouse model (Aldrovandi
and Zack, 1996), and it enhances viral replication in
primary blood lymphocytes (Miller et al., 1994; Spina et
al., 1994). These observations can be correlated with a
significantly reduced viral load in the absence of a func-
tional Nef protein.
In recent years, at least three major functions of Nef
have been revealed. First, Nef enhances the infectivity of
viral particles (Aiken and Trono, 1995; Chowers et al.,
1995; Schwartz et al., 1995). Second, Nef leads to a
markedly reduced expression of CD4 and MHC I mole-
cules on the plasma membrane (Garcia and Miller, 1991;
Schwartz et al., 1996). Third, Nef influences cellular sig-
naling pathways (Marsh, 1999).
On the molecular level, a number of cellular proteins
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246interact with different motifs in Nef. Its proline-rich motif
is required for signal transduction. It is a docking site for
SH3-containing proteins, which include Src-family ki-
nases and exchange factors for the small GTPases of the
Rho family (Baur et al., 1997; Brown et al., 1999; Fackler
et al., 1999; Lee et al., 1996; Saksela et al., 1995). Fur-
thermore, Nef associates with a p21-activated kinase
(PAK)-like kinase (Manninen et al., 1998; Nunn and
Marsh, 1996; Sawai et al., 1995; Wiskerchen and Cheng-
Mayer, 1996), which was identified as PAK1 and/or PAK2
(Arora et al., 2000; Fackler et al., 2000; Renkema et al.,
1999). Mutations in two arginines at positions 137 and
138 in Nef from SIV, which are required for the binding of
PAK, reverted rapidly and the restoration of the wild-type
sequence occurred prior to disease progression in rhe-
sus macaques (Khan et al., 1998; Sawai et al., 1995). In
addition, the proline-rich motif in Nef is essential for the
coprecipitation of active PAK with Nef (Manninen et al.,
1998; Sawai et al., 1995; Wiskerchen and Cheng-Mayer,
1996). Thus a functional connection was established
between these two motifs and PAK activation. Together
with the finding that the small GTPases Rac1 and Cdc42
are required for effects of Nef on viral production (Lu et
al., 1996), it appears that Nef assembles a large signaling
complex or signalosome.
Class Ia phosphatidylinositol-3-kinases (PI3K) consist
of a regulatory and a catalytic subunit. To date, five
isoforms and spliced variants, respectively, of the regu-
latory subunit are known (Fruman et al., 1998): two 85-
kDa proteins (p85 and p85), two 55-kDa proteins (p55
and p55), and one 50-kDa protein (p50). All regulatory
subunits contain two SH2 domains interrupted by theKey Words: HIV; SIV; Nef; accessory proteins; signal tra
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binding motif for the catalytic subunit (p110BD). The SH2nsducti
domains normally bind tyrosine-phosphorylated YxxM
motifs of receptors and recruit the associated catalytic
subunit to the membrane. Thus, the lipid kinase is
brought in close contact to its membrane-bound sub-
strates. There exist three class Ia catalytic isoforms of
110 kDa (p110, p110, and p110; Vanhaesebroeck and
Waterfield, 1999). After the generation of phosphatidyl-
inositol (PtdIns)-3,4,5-Pi, a variety of proteins are re-
cruited to different membranes via their lipid binding
domains. Among them are exchange factors for the small
GTPases of the Rho and Arf family and PDK-1 (Funaki et
al., 2000; Zohn et al., 1998). The relocalization of these
proteins initiates a broad range of cellular effects like
proliferation, differentiation, membrane ruffling, preven-
tion of apoptosis, and certain vesicular transport func-
tions.
Nef can interfere with PI3K signaling (Graziani et al.,
1996). In addition, Nef can coprecipitate a lipid-kinase
activity, which correlates with its internalization of CD4
(Kim et al., 1999). In a recent report this association
between Nef and PI3K activity influenced cell survival
(Wolf et al., 2001). Furthermore, the specific inhibitors of
PI3K, Wortmannin and Ly294002, block effects of Nef on
interleukin-2 production (Schibeci et al., 2000) and Nef-
dependent transport of MHC I to internal compartments
(Swann et al., 2001). However, no direct association be-
tween Nef and PI3K had been reported. In this study, we
found that Nef binds to the regulatory p85 subunit of
class Ia PI3K. This interaction was functional because
the selective inhibition of PI3K decreased the activity of
PAK, which was coprecipitated by Nef. Evidence is pre-
sented which supports the idea that Nef assembles PI3K,
Vav, and PAK into a signaling complex, which we name a
signalosome. In terms of viral replication, this signalo-
some was required for the increased production of HIV-1
in a Nef-dependent manner.
RESULTS
Nef binds to the regulatory p85 subunit of PI3K
It had been demonstrated that Nef associates with
PI3K activity (Kim et al., 1999) and can block PDGF-
receptor-mediated signaling via PI3K (Graziani et al.,
1996). Therefore, we hypothesized that it might recruit
the catalytic p110 subunit of PI3K via its regulatory p85
subunit, which contains different protein–protein interac-
tion domains (Fig. 3A).
The ectopic expression of the CD8–Nef chimera and
p85 was used for the coimmunoprecipitations of these
proteins in COS cells (Fig. 1A, lane 3). We used Nef from
HIV-1SF2, which is abbreviated as Nef throughout this
study. Because CD8 did not alter its cellular effects and
provided a convenient tag to precipitate Nef (Baur et al.,
1994), we chose the CD8–Nef fusion protein for this
study. Additionally, the -CD8 antibody did not immuno-
precipitate p85 when only the truncated CD8 protein,
which lacked Nef, was expressed (Fig. 1A, lane 1). Fi-
nally, without the ectopic expression of the HA-epitope-
tagged p85 protein, no coimmunoprecipitation was ob-
served when the -HA antibody was used in Western
blotting (Fig. 1A, lane 2), indicating a specific association
between Nef and p85 in cells.
The association between Nef and p85 could also be
demonstrated with the hybrid GST–Nef protein ex-
pressed in Escherichia coli. Indeed, compared to a con-
trol experiment with GST alone, GST–Nef (Fig. 1B, lane 2)
and GST–Nef(59–206) (Fig. 1B, lane 3) fusion proteins
precipitated p85 from COS lysates. In Fig. 1B, lanes 4 to
6, a control experiment with Vav is presented. Vav was
identified as a direct binding partner of the proline-rich
motif in Nef (Fackler et al., 1999).
Furthermore, p85, which was coexpressed from bac-
ulovirus in insect cells and purified extensively, bound to
the GST–Nef fusion protein (Fig. 2A, lane 3). This asso-
ciation in vitro did not depend on other cellular proteins,
as the precipitation efficiency of p85 with the GST–Nef
FIG. 1. Nef binds to p85. (A) Coimmunoprecipitation of p85 with Nef.
The CD8–Nef fusion protein and p85 protein were coexpressed in COS
cells. The CD8–Nef chimera was immunoprecipitated with the -CD8
antibody. Top: Western blot (WB) of HA-epitope-tagged p85 after pre-
cipitation of the CD8–Nef fusion (lane 2 to 3) or the truncated CD8
proteins (CD8-T, lane 1). Middle: Western blot of COS cell lysates to
control for the expression of p85. Bottom: Western blot of COS cell
lysates to control for Nef expression. The heterogeneity of the CD8–Nef
chimera can be explained by different glycosylation patterns of CD8. (B)
The GST–Nef chimera binds to p85. HA-epitope-tagged p85 and Myc-
epitope-tagged Vav were expressed in COS cells. Lysates were used to
precipitate p85 and Vav with GST, GST–Nef or GST–Nef (59–210) chi-
meras as indicated. Western blotting was performed with -HA (p85) or
-Myc antibodies (Vav). Top: Detection of p85 after precipitation with
GST fusion proteins. Bottom: Western blotting to control for the expres-
sion of p85 and Vav.
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fusion protein did not change when the binding assay
was performed in the presence of COS lysates (Fig. 2A,
compare lanes 3 and 4). Additionally, p85, which was
transcribed and translated in vitro using the rabbit reticu-
locyte lysate, could be precipitated with the hybrid GST–
Nef protein (data not shown). However, Nef had no ef-
fects on the catalytic properties of the p110 catalytic
subunit of PI3K (Fig. 2B). Thus, Nef binds directly to the
regulatory p85 subunit of PI3K.
Nef binds to the C-terminus of p85
Next, we wanted to determine which of the multiple
domains of p85 is responsible for the recognition of Nef.
Several deletion mutant p85 proteins were expressed in
COS cells. Lysates were incubated with the GST–Nef
chimera (Fig. 3). Compared to the GST control, the dele-
tion of the N-terminal SH3 or Bcr or the C-terminal SH2
domain did not abolish the binding to Nef (Fig. 3B,
grouped lanes 1 to 3). In contrast, the mutant p85 protein
bearing a deletion of its p110-binding domain interacted
poorly with Nef (Fig. 3B, grouped lane 4). Moreover, the
SH3 domain in p85 did not participate in this binding (Fig.
3B, grouped lane 2). Additionally, the GST–Nef chimera
bearing mutations of both prolines to alanines in the
proline-rich motif (76PQVPLR81) still bound to p85 (data
not shown). Finally, only the C-terminus of p85 coprecipi-
tated with the hybrid GST–Nef protein (Fig. 3B, grouped
lanes 6 and 7). Therefore, we conclude that the C-termi-
nal region of p85, which includes the p110-binding do-
main, is required for the binding between Nef and p85.
Nef from HIVF12 binds poorly to p85
To identify the p85 binding site on Nef, Nef proteins
from HIVSF2 and HIVF12 were used. Ten residues in these
Nef proteins differ within the region (Fig. 4A) which was
sufficient for the interaction between Nef and p85 (Fig.
1B, lane 3). But only 3 of these 10 amino acids, located in
the C-terminal part, affect highly conserved positions in
Nef (d’Aloja et al., 1998). For the binding assay we chose
the E140G variant of NefF12, because this fusion protein
could be obtained readily from E. coli. Indeed, the inter-
FIG. 3. Nef binds to the C-terminal region of p85. (A) The domain
organization of p85, together with different deletion mutant p85 pro-
teins. These deletions were used to dissect the binding between Nef
and p85. The amino acid positions are given. A dashed line represents
internal deletions. All p85 proteins were His-epitope-tagged. SH3, Src-
homology domain 3; Bcr, breakpoint cluster region; CSH2 and NSH2, C-
and N-terminal Src-homology domains 2; p110, binding region of the
p110 catalytic domain. (B) Identification of the region in p85 that medi-
ates Nef binding. Different deletion mutants of p85 were expressed in
COS cells. The GST–Nef fusion protein was used to pull down p85. For
all p85 proteins, a control with the GST protein clone was included. Top:
Western blotting of p85 after precipitation with -His antibodies. Bot-
tom: Western blotting of the different mutant p85 proteins with -His
antibodies. The numbering is the same as in A.
FIG. 2. Nef binds to p85 without the help of cellular partners and
does not influence PI3K activity. (A) In vitro binding of Nef and PI3K.
Western blotting with -EE antibodies of bound p85, which was purified
from insect cells as a p85/p110 complex and pulled down with GST and
GST–Nef fusion proteins. GST–Nef* indicates that the binding reaction
was carried out in the presence of lysates from COS cells. (B) Activity
of PI3K purified from insect cells in the presence of Nef. Different
amounts of the p85/p110 complex were incubated with phosphatidyl-
inositol-4,5-phosphate in the presence or absence of Nef as indicated.
The phosphorylation of the phosphoinositide with isotope-labeled ATP
was quantified with liquid scintillation counting as described under
Materials and Methods. The data show the means and standard
deviations of two experiments.
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action was diminished greatly with this GST–NefF12
E140G chimera (Fig. 4B, lanes 2 and 3). As the input of
GST–NefF12 E140G was greater than for the GST–NefSF2
fusion protein, differences in the precipitation efficiency
of p85 between NefF12 and NefSF2 are even more signifi-
cant. Thus, we identified amino acid positions in Nef
which are important for the binding of p85.
PI3K is required for the activation of PAK by Nef
To examine a functional relationship between Nef and
p85, the Nef-associated PAK activity was measured. It
could be demonstrated that the small GTPases Cdc42
and Rac1, which are upstream of PAK, are involved in this
signaling pathway (Lu et al., 1996; Nunn and Marsh,
1996). Studies which demonstrated that PI3K is required
for the activation of Cdc42 and Rac1 (Gringhuis et al.,
1998) spurred us into looking at the contribution of PtdIns
phosphates to the Nef-associated kinase activity.
In Fig. 5, PAK activity was detected in an in vitro kinase
assay. Recovery of this activity depended strictly on Nef
(Fig. 5, lanes 1 and 2). Next, we assayed the activity of
PAK in the presence of Ly294002, which is a specific
inhibitor of PI3K. In Fig. 5, lanes 3 to 5, the activity of PAK
was decreased with increasing concentrations of this
inhibitor. The active working concentration of 3 M
Ly294002 is close to the reported concentration of 1 M,
which is specific for mammalian PI3K (Funaki et al.,
2000). In addition, it was possible to inhibit PAK with the
coexpression of p85 (Fig. 5, lanes 6 and 7) to an extent
comparable to that observed with Ly294002. This domi-
nant negative effect can be explained by the limiting
concentrations of the p110 catalytic subunit, which is
sequestered in the cytosol by the overexpression of p85
(Vanhaesebroeck and Waterfield, 1999). Moreover, these
effects are comparable to those observed previously
with dominant negative PAK, Cdc42, and Rac1 proteins
(Fackler et al., 1999, 2000). These studies established a
relationship between Nef, PAK, and PI3K.
Virion production is decreased by the inhibition of PI3K
Vav and Pix are two exchange factors of the Rho family
that have been implicated in Nef signaling. The exoge-
nous expression of a dominant-negative Vav, PAK,
Cdc42, and Rac1 protein also interfered with viral pro-
FIG. 4. Different Nef alleles bind p85 with different affinities. (A) Alignment of Nef proteins from HIV-1SF2 (NefSF2) and HIV-1F12 (NefF12). For NefF12 only
changed amino acids are given. All inverted printed letters indicate amino acids which differ considerably in the two sequences. Black triangles show
the three positions in the sequence from NefF12 which are most invariant in the Nef consensus sequence. In addition the secondary structure is given
(Geyer and Peterlin, 2001). The numbering is according to the sequence of NefF12. The alignment was generated with Alscript (Barton, 1993). (B) NefF12
binds poorly to p85. GST–Nef fusion proteins from NefSF2 and NefF12 were used to precipitate the C-terminus of p85 as described for Fig. 3. Note that
the E140G mutant of NefF12 was used. The top shows a comparison of the inputs of the GST chimeras as seen in a Coomassie blue-stained gel and
the bottom a Western blot with -His antibodies to the coprecipitated His-epitope-tagged C-terminus of p85.
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duction (Brown et al., 1999; Fackler et al., 1999). PI3K is
involved in the activation of Vav (Han et al., 1998). These
observations directed us to analyze if PI3K can also
influence the production of HIV-1.
The dominant negative effect of p85 (Fig. 5) provided a
tool to block PI3K activity during viral particle formation.
Figure 6A (left) shows the amount of p24Gag released
from COS cells with increasing amounts of p85. With the
HIV-1NL-43 provirus expressing NefSF2 (pNL-43 SF2) at
equal ratios of cotransfected p85-expression plasmid, a
small increase in p24Gag production of about 1.3-fold was
observed (Fig. 6A, lane 3). However, with a further in-
crease of p85 (Fig. 6A, lanes 5 and 7) the release of
virions was decreased fourfold, which corresponds to
the inhibition of PAK activity as shown in Fig. 5. Interest-
ingly, this effect was Nef-dependent. No decrease of viral
production was observed with a proviral DNA which
lacked a functional Nef-coding sequence (Fig. 6A,
pNL-43 Nef, white bars). The small increase in viral
FIG. 6. PI3K is required for the increased production of HIV-1 by Nef. (A)
The overexpression of p85 blocks viral production. pNL-43 NefSF2 and
pNL-43 Nef were cotransfected into COS and Jurkat cells together with
increasing amounts of pMT2:p85 (the ratio of pMT2:p85 over proviral DNA
was 0, 1, 2, and 4 for COS cells and 4 for Jurkat cells). After 48 h, the
supernatants from COS cells were assayed for the amount of p24Gag, and
5 days after transfection, the activity of reverse transcriptase (RT) was
measured in the supernatants from Jurkat cells. The RT activity with
pNL-43 NefSF2 was arbitrarily set to 1 and all other data are relative values.
Results represent the mean of three experiments. (B) Western blotting with
-HA antibodies controlled for the expression of p85 in COS cells (top).
The black triangles indicate increasing amounts of p85 as described in A.
Western blots at the bottom show the amounts of actin in the COS cell
experiment, which were detected with -actin antibodies. (C) p24 expres-
sion in COS cells is not influenced by p85. Western blots with -p24 after
the transfection of COS cells with proviral vectors in the presence and
absence of p85. The ratio of p85 to proviral vector was 4 as in A. The
expression of p85 was controlled in a Western blot with the -HA antibody.
FIG. 5. PI3K is required for the Nef-associated PAK activity. (A) The
CD8–Nef chimera was expressed in COS cells and immunoprecipi-
tated from the cell lysate with -CD8 antibodies. Subsequently, the
autophosphorylation of coprecipitated PAK was measured in an in vitro
kinase assay (top). The bottom shows the expression of the CD8–Nef
chimera probed by Western blotting with -Myc antibodies. In lane 1,
the truncated CD8 protein was used as a control. In lanes 1–5, DMSO
or Ly294002 was added to the COS cells. In lane 7, p85 was coex-
pressed with the CD8–Nef chimera. (B) The amount of phosphorylated
PAK in A was quantified with the phosphoimager technique. The back-
ground as seen in A (lane 1) was subtracted and the values of the
controls (A, lanes 2 and 6) were set to 1 and the other values are given
accordingly. The numbering of the bars corresponds to the lanes in A.
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production in the presence of Nef at lower concentra-
tions of p85 most likely reflects the saturation of all Nef
proteins with p85, thus enabling a better competition for
the limiting amounts of p110. At higher expression levels,
cytosolic p85 accumulates and the dominant-negative
effects occur. Expression levels of p85 were determined
by Western blotting (Fig. 6B, top). Furthermore, we tested
if the influence of PI3K on viral production is at the level
of the processing of the GagPol precursor. Figure 6C
shows that Nef is not involved in the processing of p24
(lanes 1 and 3) and that the inhibition of PI3K via the
overexpression of p85 did not influence the amount of
processed p24 (lanes 1 and 2).
Because T cells are the primary targets of HIV-1, we
also examined if PI3K activity is required for the produc-
tion of virions in Jurkat cells. The supernatant of Jurkat
cells was assayed for reverse transcriptase activity 5
days posttransfection because virus could be readily
detected after 4 to 5 days (data not shown). Indeed, an
even larger reduction of viral particle production (10-fold)
could be achieved in this cell type with the coexpression
of p85 in the presence of Nef (Fig. 6A, right, lanes 9 and
11). Again, no change in viral production was observed
when a Nef-deficient provirus was used (lanes 10 and
12). In summary, the binding between Nef and PI3K leads
to a productive advantage for HIV-1.
DISCUSSION
In this report, we found a direct association between
Nef and PI3K. The C-termini of p85 and Nef mediated this
interaction without influencing the catalytic properties of
the lipid kinase. The pharmacological inhibition of the
catalytic p110 subunit and the overexpression of the
regulatory p85 subunit decreased the activation of PAK
and thus blocked the signaling by Nef. Finally, Nef-me-
diated PI3K effects could be correlated with the in-
creased production of HIV-1. We conclude that the sig-
nalosome, which is assembled by Nef, starts with PI3K
and activates PAK.
The C-termini of p85 and Nef bind to each other. In
p85, the C-terminal region, overlapping the p110-binding
site, mediated the interaction. A comparison of the Nef
proteins from HIV-1SF2 and HIV-1F12 revealed several
amino acid positions, mostly at the C-terminus in Nef,
which could be important for the recognition of p85. G158
and G177 are found close together in the tertiary struc-
ture of Nef at the bottom of the flexible loop (Geyer and
Peterlin, 2001) and are required for optimal viral produc-
tion and infectivity (Fackler et al., 2001). These residues
are most likely important for the recognition of p85.
Recently, Wolf et al. (2001) also defined the C-terminus of
Nef as the interaction site for p85. Together, the mem-
brane-bound Nef recruits PI3K via its regulatory subunit,
which parallels the tyrosine kinase-mediated PI3K acti-
vation. However, a major difference with Nef is its inde-
pendence of tyrosine phosphorylation. This could enable
the virus to recruit PI3K or Src-family kinases even when
receptor signaling is low, i.e., while cells are in a quies-
cent state. Additionally, PtdIns-3,4,5-Pi has been reported
to compete with cellular binding partners for p85 (Rameh
et al., 1995). Therefore, another advantage of this uncon-
ventional recognition of p85 by Nef might be to circum-
vent such a negative feedback loop.
The direct recruitment of PI3K could also explain the
interference of signaling from the PDGF receptor by Nef
(Graziani et al., 1996). Additionally, it reveals how Nef
activates the serum response pathway (Lu et al., 1996)
and enhances the production of interleukin-2 (Schibeci
et al., 2000). The latter phenotype has been correlated
with a decreased threshold for T cell activation and
increased viral replication (Baur et al., 1994; Manninen et
al., 2000). As PI3K is a major component of the T-cell
receptor synapse, these observations explain why the
Nef expression profile parallels that of the activated T
cell receptor (Simmons et al., 2001). Moreover, as PI3K
also regulates Arf exchange factors, effects of Nef on
cellular trafficking and endocytosis could also depend on
PtdIns-3-Pi (Funaki et al., 2000; Vanhaesebroeck and
Waterfield, 1999). They might facilitate the transport of
viral precursors to the plasma membrane and target
cell-surface proteins to the endosomal machinery. The
latter scenario could explain the observed effects of Nef
on MHC I transport (Swann et al., 2001). Another advan-
tage for the virus could be the protection of infected cells
from apoptosis, thus increasing levels of viral replication
(Wolf et al., 2001).
Several groups reported the association between Nef
and active PAK (Arora et al., 2000; Fackler et al., 2000;
Renkema et al., 1999). Our study sheds more light onto
the molecular details that underlie this activation. Vav
and Pix are two Dbl-homology exchange factors for the
Rho family that bind to Nef (Brown et al., 1999; Fackler et
al., 1999). Moreover, for Vav, a regulatory effect of PtdIns-
4,5-Pi and PtdIns-3,4,5-Pi had been demonstrated clearly
(Han et al., 1998). Furthermore, the activation of Cdc42
and Rac1, which are implicated in Nef signaling (Lu et al.,
1996; Nunn and Marsh, 1996), also depends on PI3K. The
latter dependency most likely reflects the co-occurrence
of the Dbl-exchange motif and the PH domain, which
binds to PtdIns-3,4,5-Pi (Zohn et al., 1998). Interestingly,
NefF12 does not activate PAK unless G177 is reverted to
glutamate, the corresponding amino acid in the consen-
sus Nef sequence (d’Aloja et al., 2001). The PI3K depen-
dency of PAK activation by Nef provides an explanation
for this observation. Additionally, because these posi-
tions are not involved in PAK or Vav recognition, it
strengthens the idea that the sequence deviations in Nef
from HIV-1F12 are responsible for the diminished interac-
tion with p85. The intrinsic activities of PI3K or Vav (T.L.
and M.P., unpublished observation) are not increased by
this recruitment. Taken together, a picture emerges in
which Nef recruits all required components for the acti-
vation of PAK into a single signalosome (Fig. 7). Such a
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scenario explains the inhibitory effects of Ly294002 and
the overexpression of p85 on PAK observed by us and
others (Wolf et al., 2001). The different nature of both
inhibitors makes it unlikely that the decrease in PAK
activity is solely due to a disturbance of the association
between Nef and PAK. In summary, Nef can be compared
to adapter proteins like Ste5, Jip-1, or Mp1, which coor-
dinate signaling cascades in the eukaryotic cell (Gar-
rington and Johnson, 1999).
Finally, we were able to demonstrate an effect of PI3K
on viral production. Because a Nef-deficient provirus
was not affected by the inhibition of PI3K, this phenotype
depended on Nef. The requirement for active PI3K for
viral production was more pronounced in Jurkat than in
COS cells. Jurkat cells have no active PTEN, a phospha-
tase which inactivates the phosphoinositides generated
by PI3K (Shan et al., 2000). Therefore, they contain ele-
vated levels of phosphorylated lipids, which might ex-
plain the higher susceptibility of viral production in re-
sponse to an inhibition of PI3K. Also, Wolf et al. (2001)
reported an up to eightfold effect on viral production in
Jurkat cells when the Nef signalosome is inhibited. As
the processing of p24 was not affected by PI3K, this
observation indicates that only the release of virions was
affected. In addition to PI3K, PAK and the proline-rich
motif in Nef have been demonstrated to be required for
viral production (Fackler et al., 2000; Lu et al., 1996). An
even more drastic effect on viral production could be
demonstrated with Nef from HIV-1F12 (D’Aloja et al., 1998),
which had a greatly diminished affinity for p85. Recently,
Wu and Marsh (2001) demonstrated that Nef is ex-
pressed before viral integration and stimulates viral par-
ticle formation in resting T cells. Together, these findings
strengthen the role for Nef on viral production. To
achieve this effect, Nef must bind to PI3K and contain
intact PxxP and diarginine motifs. A putative location
where the signalosome facilitates viral budding could be
the lipid rafts compartment to which Nef localizes (Wang
et al., 2000; Zheng et al., 2001).
Taken together, the binding between PI3K and Nef and
the inclusion of this lipid kinase in Nef-mediated pro-
cesses complete the picture of the known signaling
intermediates of Nef for the replication of HIV-1. Our
study also offers a new therapeutic target for blocking
interactions between the virus and the host, which could
decrease levels of HIV-1 in the body.
MATERIALS AND METHODS
Plasmids and proteins
The coding sequences of the CD8–NefSF2 (CD8–Nef)
chimera, the CD8 fusion part (CD8-T), and Vav were
expressed from pEF as described (Fackler et al., 1999).
The CD8–Nef and Vav sequences contained a C-terminal
Myc tag. The different p85 mutants, as shown in Fig. 2A,
were expressed from pMT2 and had a His tag at the
C-terminus. In addition full-length p85 with a HA tag was
expressed from pMT2. The coding sequences of full-
length Nef from SF2, 233, and F12 and Nef(59–210) from
SF2, p85-NSH2 (amino acids 334–443, GST–NSH2), and
p85-CSH2 (amino acids 601–724, GST–CSH2) were ex-
pressed in E. coli from pGEX4T1. p85 (tagged with a Glu
epitope) purified from insect cells after baculovirus ex-
pression was generously provided by A. Abo. The full-
length proviral DNA for virus production was derived
from pNL-43. pNL-43 NefSF2 contained the nefSF2 se-
quence instead of the nefNL-43 sequence and pNL-43
Nef is a nef-defective HIV-1.
Cell culture and transfection
COS cells were maintained in DMEM containing 10%
fetal calf serum according to standard procedures.
Transfections were performed with Lipofectamine (Gibco,
Grand Island, NY) according to the manufacturer’s pro-
tocol. Jurkat cells were cultured in RPMI supplemented
with 10% fetal calf serum. Transfections were carried out
by electroporation (0.25 kV, 950 F) with a Bio-Rad
Genepulser as described (Fackler et al., 1999).
Immunoprecipitations
Transfected COS cells were washed with phosphate-
buffered saline (PBS) twice and lysed on ice in buffer A
(50 mM Tris–HCl, pH 7.4, 100 mM NaCl, 5 mM MgCl2, 1%
IGPAL, 1 mM PMSF, protease inhibitor cocktail (Sigma,
St. Louis, MO)). The lysate was centrifuged at 4°C,
12,000g for 10 min, and the supernatant was incubated
with CD8-Dynabeads (Dynal AS, Oslo, Norway) for 45
min, washed in buffer A four times, and resuspended in
sodium dodecyl sulfate (SDS) sample buffer. Western
FIG. 7. Schematic representation of the signalosome assembled on
Nef. The emphasis is on the linear arrangement of the signaling
cascade. Nef binds to the cytosolic signaling partners PI3K, Vav, and
PAK. Rac1/Cdc42 and Nef bear lipid modifications, which localize them
to membranes. Nef forms multimers, which could aggregate the sig-
nalosome.
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blot analysis was performed according to standard pro-
cedures by using the ECL kit (Amersham–Pharmacia
Biotech, Piscataway, NJ). p85 was detected with an -HA
antibody (HA-probe Y-11; Santa Cruz Biotechnology,
Santa Cruz, CA) and Nef with an -Myc antibody (c-Myc
A14; Santa Cruz Biotechnology).
GST fusions and in vitro binding studies
GST–Nef from SF2, 233, and F12 and GST–Nef(59–210)
from SF2, GST–NSH2, and GST–CSH2 fusion proteins
were expressed in E. coli BL21 and purified with gluta-
thione–Sepharose (Amersham–Pharmacia Biotech) ac-
cording to standard procedures as well as GST alone.
Nef(59–210) was cleaved from the GST fusion part with
thrombin while bound to the GSH–Sepharose. The
Nef(59–210) protein was obtained from the supernatant
and further purified by gel filtration. All proteins were
analyzed with SDS–PAGE and the concentration was
estimated by comparison to a bovine serum albumin
(BSA) control. In addition the concentration of total fusion
proteins bound to GSH beads was determined with the
Bradford reagent (Pierce, Rockford, IL), again using BSA
as a standard. The variations between the two methods
were within 10%. Lysates from COS cells expressing the
CD8–Nef chimera or the purified p85/p110 complex from
insect cells were incubated with 20 M GST-fusion pro-
teins coupled to glutathione–Sepharose for 45 min at
4°C in buffer A, followed by three wash steps in the same
buffer. The glutathione beads were resuspended in SDS
sample buffer and analyzed via Western blot. For p85
constructs an -His antibody (His-probe H15; Santa Cruz
Biotechnology) or -EE antibody (Babco, Berkeley, CA)
were used.
PI3K assay
The catalytic (p110) and regulatory (p85) subunits from
the baculovirus SF9 expression system were incubated
with phosphatidylinositol-4,5-phosphates, 0.1 mM ATP,
and 1 Ci [-32P]ATP for 15 min at room temperature. The
phosphoinositides were immobilized on SAM precursor
membranes (Promega, Madison, WI). The reaction was
stopped with 0.75 M guanidinium hydrochloride and the
membranes were washed two times with 2 M NaCl,
three times with 2 M NaCl/1% H3PO4, and two times with
water. The dried membranes were subjected to liquid
scintillation counting.
In vitro kinase assay
The detection of Nef-associated PAK kinase was per-
formed as described (Fackler et al., 2000). Briefly, trans-
fected cells were lysed in KEB (50 mM Tris–HCl, pH 8.0,
140 mM NaCl, 2 mM EDTA, 0.5% IGEPAL, 10% (v/v)
glycerol, 2 mM Na2VO4, 1 mM PMSF, protease inhibitor
cocktail (Sigma)) for 30 min at 4°C and the supernatants
were immunoprecipitated with CD8-Dynabeads for 1 h at
4°C. After five wash steps in KEB the Dynabeads were
resuspended in 100 l KAB (50 mM Tris–HCl, pH 8.0, 100
mM NaCl, 5 mM MgCl2, 1% (v/v) Triton X-100, 200 Ci/ml
[-32P]ATP). The kinase reaction was performed for 5 min
at room temperature. The beads were washed again four
times in KEB and resuspended in SDS sample buffer.
The proteins were separated by SDS–PAGE and the
dried gels subjected to autoradiography with the help of
a phosphoimager (Bio-Rad, Cambridge, MA). The inten-
sity of the PAK bands was quantified with Molecular
Analyst (Bio-Rad).
Virus production assay
COS and Jurkat cells were transfected with proviral
DNA and pMT2:p85. Two (COS) or five (Jurkat) days after
transfection the supernatants were harvested, centri-
fuged for 2 min at 2000g, and stored at 20°C. Virus
production was quantified by p24Gag-capture ELISA
(Fackler et al., 2000) or activity of reverse transcriptase
(Baur et al., 1997). For the reverse transcriptase assay
the activity without p85 coexpression was arbitrarily set
to 1. The cells were washed twice in PBS and lysed in
PBS, 1% (v/v) Triton X-100, 1 mM PMSF, and protease
inhibitor cocktail (Sigma). The lysate was cleared by
centrifugation and checked for comparable total protein
content with BCA reagent (Pierce). Differences in protein
content between different samples were within 10% vari-
ation. Samples of the lysate were used to check for
expression of p85 with an -HA and -actin antibody
(Actin C-11; Santa Cruz Biotechnology).
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